Metropolis Network Expansion and Revenue Growth Strategy
Ref: MHL/Sec&Legal/2023-24/84
Date: February 02, 2024
To,
Head, Listing Compliance Department
BSE Limited,
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai - 400 001.
Scrip Code: 542650
To,
Head, Listing Compliance Department,
National Stock Exchange of India Limited
Exchange Plaza, Plot No. C/1. G Block,
-
Bandra Kurla Complex, Bandra (East),
Mumbai-400051
Scrip Symbol: METROPOLIS
Sub: Intimation of Investor Presentation.
Dear Sir/Madam,
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we are enclosing herewith Investor Presentation for the quarter ended
December 31, 2023.
You are requested to take the above information on record.
Thanking you,
Yours faithfully
For Metropolis Healthcare Limited
Neha
Dilip Shah
Neha Shah
Digitally signed by
Neha Dilip Shah
Date: 2024.02.02
19:08:25 +05'30'
Interim Company Secretary &
Compliance Officer
Membership No: A51465
Encl. A/a
METROPOLIS
The Pathology Specialist
BLOOD TESTS • DIAGNOSTICS WELLNESS
Metropolis Healthcare Limited
Registered Office: 4th Floor, East Wing, Nirlon House, Dr. Annie Besant Road, Worli, Mumbai 400018,
Maharashtra, India.
Corporate Office & Global Reference Laboratory: 4th Floor, Commercial Building-1A, Kohinoor Mall, Vidyavihar
(W), Mumbai - 400 070.
CIN: L73100MH2000PLC192798 Tel No.: 8422 801 801 Email: [email protected]
Website: www.metropolisindia.comView entire presentation